{"product_id":"1002-fda-approval-bla-125062-674","title":"1002FDAA2405: FDA Approval BLA 125062\/674","description":"\u003cp\u003e\u003ca data-sheets-formula-bar-text-style=\"font-size:13px;color:#1155cc;font-weight:normal;text-decoration:underline;font-family:'docs-Calibri';font-style:normal;text-decoration-skip-ink:none;\" class=\"waffle-rich-text-link\" data-sheets-formula-bar-text-link=\"https:\/\/drive.google.com\/drive\/u\/0\/folders\/1Qx78z5QdHq76C0WQCim2e7Lijp9lv9Ix\"\u003eSupplemental drug approval package for Octagam, BLA 125062\/674, approved 07\/15\/2021 for dermatomyositis\u003c\/a\u003e\u003c\/p\u003e\n\u003c!----\u003e","brand":"FDA","offers":[{"title":"Default Title","offer_id":45836643238052,"sku":"1002FDAA2405","price":56.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/foiadocs.com\/products\/1002-fda-approval-bla-125062-674","provider":"FOIA Document Source","version":"1.0","type":"link"}